1-.BETA.-D-Arabinofuranosylcytosine (Ara-C) -induced Apoptosis in the Rat Fetal Tissues and Placenta
Yamauchi, H.; Katayama, K.; Yasoshima, A.; Uetsuka, K.; Nakayama, H.; Doi, K.
Journal of Toxicologic Pathology 16(4): 223-229
2003
ISSN/ISBN: 0914-9198 Accession: 080856111
Full-Text Article emailed within 1 workday
Payments are secure & encrypted
References
Yamauchi, H.; Katayama, K.-i.; Ueno, M.; Uetsuka, K.; Nakayama, H.; Doi, K. 2004: Involvement of p53 in 1-beta-D-arabinofuranosylcytosine-induced trophoblastic cell apoptosis and impaired proliferation in rat placenta Biology of Reproduction 70(6): 1762-1767Liliemark, J.O.; Plunkett, W.; Dixon, D.O. 1985: Relationship of 1-beta-D-arabinofuranosylcytosine in plasma to 1-beta-D-arabinofuranosylcytosine 5'-triphosphate levels in leukemic cells during treatment with high-dose 1-beta-D-arabinofuranosylcytosine Cancer Research 45(11 Part 2): 5952-5957
Stadheim, T.A.; Kucera, G.L. 1999: Wortmannin attenuates 1-beta-D-arabinofuranosylcytosine-induced apoptosis Proceedings of the American Association for Cancer Research 40: 581
Yamauchi, H.; Katayama, K-Ichi.; Ueno, M.; Uetsuka, K.; Nakayama, H.; Doi, K. 2004: Involvement of p53 in 1-beta-D-arabinofuranosylcytosine-induced rat fetal brain lesions Neurotoxicology and Teratology 26(4): 579-586
Datta, R.; Banach, D.; Kojima, H.; Talanian, R.V.; Alnemri, E.S.; Wong, W.W.; Kufe, D.W. 1996: Activation of the CPP32 protease in apoptosis induced by 1-beta-D-arabinofuranosylcytosine and other DNA-damaging agents Blood 88(6): 1936-1943
Jarvis, W.D.; Gewirtz, D.A.; Petit, G.R.; Povirk, L.F.; Swerdlow, P.S.; Grant, S. 1993: Potentiation of 1-beta-D-arabinofuranosylcytosine -induced apoptosis by bryostatin I in HL-60 promyelocytes Quantitation of DNA fragmentation Proceedings of the American Association for Cancer Research 34: 289
Stadheim, T.A.; Saluta, G.R.; Kucera, G.L. 2000: Role of c-Jun N-terminal kinase/p38 stress signaling in 1-beta-D-arabinofuranosylcytosine-induced apoptosis Biochemical Pharmacology 59(4): 407-418
Wang, S.; Wang, Z.; Grant, S. 1999: Effect of the PKC activator bryostatin 1 on 1-beta-D-arabinofuranosylcytosine induced apoptosis in Bcl-xL-overexpressing human leukemia cells Proceedings of the American Association for Cancer Research 40: 485
Ray, S.; Ponnathpur, V.; Huang, Y.; Tang, C.; Mahoney, M.E.; Ibrado, A.M.; Bullock, G.; Bhalla, K. 1994: 1-beta-D-arabinofuranosylcytosine-, mitoxantrone-, and paclitaxel-induced apoptosis in HL-60 cells: improved method for detection of internucleosomal DNA fragmentation Cancer ChemoTherapy and Pharmacology 34(5): 365-371
Wang, S.; Wang, Z.; Grant, S. 2003: Bryostatin 1 and UCN-01 potentiate 1-beta-D-arabinofuranosylcytosine-induced apoptosis in human myeloid leukemia cells through disparate mechanisms Molecular Pharmacology 63(1): 232-242
Takauji, R.; Yoshida, A.; Iwasaki, H.; Tohyama, K.; Ueda, T.; Nakamura, T. 1995: Enhancement of Ca(2+)-dependent endonuclease activity in L1210 cells during apoptosis induced by 1-beta-D-arabinofuranosylcytosine: possible involvement of activating factor(s) Japanese Journal of Cancer Research: Gann 86(7): 677-684
Badran, A.; Iwasaki, H.; Wano, Y.; Kishi, S.; Ueda, T. 2001: Time sequential expression of markers of apoptosis induced by 1-beta-D-arabinofuranosylcytosine in human T-lymphoblastic leukemia CCRF-CEM cells Anticancer Research 21(3b): 1987-1995
Wang, Z.; Wang, S.; Dai, Y.; Grant, S. 2002: Bryostatin 1 increases 1-beta-D-arabinofuranosylcytosine-induced cytochrome c release and apoptosis in human leukemia cells ectopically expressing Bcl-x(L) Journal of Pharmacology and Experimental Therapeutics 301(2): 568-577
Grant, S.; Freemerman, A.J.; Birrer, M.J.; Chelliah, J.; Jarvis, W.D. 1995: Differential role of c-jun in 1-beta-D-arabinofuranosylcytosine-induced differentiation versus apoptosis in U937 human myeloid leukemia cells Blood 86(10 Suppl 1): 328A
Kuwakado, K.; Kubota, M.; Bessho, R.; Kataoka, A.; Usami, I.; Lin, Y.W.; Okuda, A.; Wakazono, Y. 1995: Augmentation by aphidicolin of 1-beta-D-arabinofuranosylcytosine-induced c-jun and NF-kappa B activation in a human myeloid leukemia cell line: correlation with apoptosis Leukemia Research 19(9): 645-650
Grant, S.; Pettit, G.R.; Povirk, L.F.; Swerdlow, P.S.; Gewirtz, D.A.; Jarvis, W.D. 1993: Divergent influences of bryostatin 1 and other pharmacological activators of protein kinase C on 1-beta-D-arabinofuranosylcytosine -induced DNA damage and apoptosis in HL-60 leukemia cells Proceedings of the American Association for Cancer Research 34: 289
Damon, L.E.; Plunkett, W.; Linker, C.A. 1991: Plasma and cerebrospinal fluid pharmacokinetics of 1-beta-D-arabinofuranosylcytosine and 1-beta-D-arabinofuranosyluracil following the repeated intravenous administration of high- and intermediate-dose 1-beta-D-arabinofuranosylcytosine Cancer Research 51(16): 4141-4145
Thottassery, J.V.; Westbrook, L.; Someya, H.; Parker, W.B. 2006: C-Abl-independent p73 stabilization during gemcitabine- or 4'-thio-beta-D-arabinofuranosylcytosine-induced apoptosis in wild-type and p53-null colorectal cancer cells Molecular Cancer Therapeutics 5(2): 400-410
Wang, S.; Vrana, J.A.; Bartimole, T.M.; Freemerman, A.J.; Jarvis, W.D.; Kramer, L.B.; Krystal, G.; Dent, P.; Grant, S. 1997: Agents that down-regulate or inhibit protein kinase C circumvent resistance to 1-beta-D-arabinofuranosylcytosine-induced apoptosis in human leukemia cells that overexpress Bcl-2 Molecular Pharmacology 52(6): 1000-1009
Grant, S.; Turner, A.; Jarvis, W.D. 1993: Modulation of 1-beta-D-arabinofuranosylcytosine -induced apoptosis by activators of protein kinase C in human promyelocytic leukemia cells Evidence for involvement of PKC down-regulation Blood 82(10 Suppl 1): 251A